Published in Women's Health Weekly, October 9th, 2003
"Preterm labor is a major cause of perinatal mortality and morbidity. However, during the past 40 years of clinical studies and despite the use of multiple therapeutic agents, the rate of preterm birth has not drastically declined. In 1991, it was estimated that in the U.S. approximately 116,000 women admitted with acute episodes of preterm labor were treated each year with ritodrine, which is the first drug approved by the Food and Drug Administration and still remains the standard therapy for treating preterm labor," investigators in Switzerland...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly